What it is: A synthetic heptapeptide derived from tuftsin, an immune peptide, developed in Russia and studied for anxiety reduction and cognitive enhancement without sedation.
Research suggests: Russian clinical studies report anxiolytic effects comparable to benzodiazepines with a notably different safety profile - no sedation, dependence, or withdrawal reported.
Best for: Anxiety and cognitive performance researchers
Key thing to know: Approved as an anxiolytic in Russia; independent large-scale trials outside Russia are essentially absent, which limits the evidence generalizability.
What is Selank?
Selank is a synthetic heptapeptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Its sequence is based on tuftsin , a naturally occurring tetrapeptide fragment of immunoglobulin G , extended with an additional tripeptide sequence to improve metabolic stability and CNS bioavailability. The resulting compound has been studied primarily for its anxiolytic and nootropic properties.
Unlike classical anxiolytics such as benzodiazepines, which work primarily through GABA-A receptor positive allosteric modulation, Selank is thought to engage multiple neurochemical systems simultaneously. It has been approved in Russia and Ukraine as an anxiolytic drug under the name "Selank" and is used clinically for generalized anxiety disorder and neurasthenia in those countries. Outside of Russia and Ukraine it remains an unapproved research compound with no regulatory status in the US, EU, or UK.
How Selank Works
Selank's anxiolytic effects are thought to involve GABAergic modulation , specifically, enhancement of GABA-A receptor sensitivity and upregulation of GABA transaminase, the enzyme that breaks down GABA. This shifts the inhibitory/excitatory balance in a calming direction without fully activating the receptor in the way benzodiazepines do, which may explain why Selank does not appear to produce tolerance, dependence, or significant sedation in the research literature.
Selank has also been shown in rodent studies to upregulate brain-derived neurotrophic factor (BDNF) in the hippocampus, an effect associated with improved stress resilience, memory consolidation, and synaptic plasticity. Additionally, Selank appears to modulate the expression of serotonin transporter genes (SLC6A4) and to influence the enkephalin system , a class of endogenous opioid peptides involved in mood and stress regulation.
Immunomodulatory effects have also been reported, with Selank influencing interleukin-6 expression and T-helper cell activity. The compound's tuftsin ancestry may account for some of this immune-regulatory profile, though the relevance to human anxiety treatment is not yet well characterized.
What Does the Evidence Show?
Multiple controlled clinical trials conducted at Russian research institutions have evaluated Selank in patients with generalized anxiety disorder and mixed anxiety-depressive disorder. These trials generally report significant reductions in anxiety scores (Hamilton Anxiety Rating Scale) compared to placebo, with some studies showing comparable efficacy to low-dose benzodiazepines. The evidence base is real, but virtually all studies originate from a single national research ecosystem, limiting independent replication.
Preclinical studies in rodents consistently show increased hippocampal BDNF expression following Selank administration. BDNF upregulation is associated with antidepressant-like behavioral changes and enhanced learning in preclinical studies. Whether this translates meaningfully to human cognitive enhancement outside of an anxiety context is not yet established in independent research.
Selank is widely discussed in nootropic communities for cognitive enhancement beyond anxiety relief. The research here is substantially thinner , primarily preclinical studies and anecdotal reports. Claims of improved memory, focus, and mental clarity in healthy individuals have not been rigorously tested in controlled human trials.
Relevant Labs to Review
If you are working with a healthcare provider to evaluate whether Selank might be relevant to your research goals, these are the biomarkers most commonly considered in the context of anxiety, stress response, and neurological health.
Commonly Researched Alongside Selank
Some researchers have explored Selank in combination with other compounds targeting overlapping or complementary pathways. These pairings are based on published research and observed mechanisms , not clinical recommendations.